Leveraging the Outpatient Pharmacy to Reduce Medication Waste in Pediatric Asthma Hospitalizations

• Published in: Journal of hospital medicine 2020-01, Vol.15 (1), p.28-34
• Main Authors: Hoefgen, Erik R, Jones, Yemisi, Courter, Joshua, Hare, Andrew, Garcia, José A Torres, Simmons, Jeffrey
• Format: Article
• Language: English
• Subjects: Administration, Inhalation; Adrenal Cortex Hormones - therapeutic use; Asthma; Asthma - drug therapy; Child; Hospitalization; Hospitals, Pediatric; Humans; Inhalers; Inpatients; Insurance coverage; Insurance Coverage - economics; Original Research; Pharmacy
• ISSN: 1553-5592; 1553-5606
• DOI: 10.12788/jhm.3275

BACKGROUND AND OBJECTIVE Previous local quality improvement focused on discharging patients with inhaled corticosteroids (ICS) “in‐hand” decreased healthcare reutilization after hospitalization for an asthma exacerbation. However, as a result of these new processes, some patients admitted for an asthma exacerbation received more than one ICS inhaler during their admission, contributing to medication waste and potential patient confusion regarding their discharge medication regimen. We sought to decrease this waste. METHODS We conducted a quality improvement project to reduce the prescribing of multiple ICS inhalers to patients at a large academic children's hospital. Our primary outcome measure was the monthly percentage of patients admitted with an asthma exacerbation who were administered more than one ICS inhaler. A secondary outcome measure evaluated the reliability of the new process of using the hospital‐based outpatient pharmacy to supply ICS “in‐hand” and verify insurance coverage. After the process map review, we hypothesized a delay in the initial ICS treatment decision would allow for both a finalized discharge medication plan and a standardized process to verify outpatient insurance coverage. RESULTS The mean percentage of patients receiving more than one ICS inhaler decreased from our baseline of 7.4% to 0.7%. Verification of outpatient prescription insurance coverage via the outpatient pharmacy increased from 0.7% to 50%. The average inpatient cost (average wholesale price) for ICS decreased by 62% to $90.25. CONCLUSIONS Our process change to use the outpatient pharmacy to dispense and verify insurance coverage for ICS medication was associated with a reduction in medication waste during admission for an asthma exacerbation.